Pharmaceutical Chemistry Journal

, Volume 24, Issue 9, pp 593–599 | Cite as

Stereoselectivity of the binding of drugs by blood plasma proteins (review)

  • A. N. Lutsevich
Molecular Biological Problems of the Creation of Drugs and Study of the Mechanisms of their Action


Organic Chemistry Plasma Protein Blood Plasma Blood Plasma Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    K. I. Bender and A. N. Lutsevich, Farmakol. Toksikol., No. 5, 110–119 (1987).Google Scholar
  2. 2.
    S. A. Pavlinov, V. K. Piotrovskii, and V. I. Metelitsa, Khim. Farm. Zh., No. 5, 517–523 (1989).Google Scholar
  3. 3.
    N. L. Shimanovskii, Farmakol. Toksikol., No. 2, 93–100 (1984).Google Scholar
  4. 4.
    F. Albani, R. Riva, M. Vontin, and A. Baruzzi, Br. J. Clin. Pharmacol.,18, 244–246 (1984).Google Scholar
  5. 5.
    T. Alebić-Kolbah, F. Kajfez, S. Rendić, et al., Biochem. Pharmacol.,28, 2457–2464 (1979).Google Scholar
  6. 6.
    T. Alebić-Kolbah, S. Rendić, Z. Fuks, et al., Acta Pharm. Jugosl.,29, 53–70 (1979).Google Scholar
  7. 7.
    E. J. Ariëns, Eur. J. Clin. Pharmacol.,26, 663–668 (1984).Google Scholar
  8. 8.
    C. von Bahr, J. Hermansson, and M. Lind, J. Pharmacol. Exp. Ther.,222, 458–462 (1982).Google Scholar
  9. 9.
    C. von Bahr, J. Hermansson, and K. Tawara, Br. J. Clin. Pharmacol.,14, 79–82 (1982).Google Scholar
  10. 10.
    S. S. Bai, U. K. Walle, M. J. Wilson, and T. Walle, Drug Metab. Dispos.,11, 394–395 (1983).Google Scholar
  11. 11.
    O. J. M. Bos, M. J. E. Fischer, J. Wilting, and L. H. M. Janssen, Biochim. Biophys. Acta,953, 37–47 (1988).Google Scholar
  12. 12.
    O. J. M. Bos, J. P. M. Remijn, M. J. E. Fischer, et al., Biochem. Pharmacol.,37, 3905–3909 (1988).Google Scholar
  13. 13.
    N. A. Brown, E. Jähnchen, W. E. Müller, and U. Wollert, Molec. Pharmacol.,13, 70–79 (1977).Google Scholar
  14. 14.
    N. A. Brown, E. Jähnchen, W. E. Müller, et al., Comp. Biochem. Physiol.,62C, 101–105 (1979).Google Scholar
  15. 15.
    F. Brünner and W. E. Müller, J. Pharm. Pharmacol.,37, 305–309 (1985).Google Scholar
  16. 16.
    F. Brünner and W. E. Müller, ibid.,39, 986–990 (1987).Google Scholar
  17. 17.
    H. Buch, J. Knabe, W. Buzello, and W. Rummel, J. Pharmacol. Exp. Ther.,175, 709–716 (1970).Google Scholar
  18. 18.
    S. Caccia, M. Ballabio, and P. De Ponte, Eur. J. Drug Metab. Pharmacokinet.,4, 129–132 (1979).Google Scholar
  19. 19.
    J. Caldwell, S. M. Winter, and A. J. Hutt, Xenobiotica,18, Suppl., 59–70 (1988).Google Scholar
  20. 20.
    C. S. Cook, A. Karim, and P. Soltman, Drug Metab. Dispos.,10, 111–114 (1982).Google Scholar
  21. 21.
    P. Dayton, R. L. Stiller, D. R. Cook, and J. M. Perel, Eur. J. Clin. Pharmacol.,24, 825–831 (1983).Google Scholar
  22. 22.
    D. E. Drayer, Clin. Pharmacol. Ther.,40, 125–133 (1986).Google Scholar
  23. 23.
    H. Echizen, B. Vogelgesang, and M. Eichelbaum, ibid.,38, 71–76 (1985).Google Scholar
  24. 24.
    M. Eichelbaum, G. Mikus, and B. Vogelgesang, Br. J. Clin. Pharmacol.,17, 453–458 (1984).Google Scholar
  25. 25.
    M. Eichelbaum, Biochem. Pharmacol.,37, 93–96 (1988).Google Scholar
  26. 26.
    A. M. Evans, R. L. Nation, L. N. Sansom, et al., Eur. J. Clin. Pharmacol.,36, 283–290 (1989).Google Scholar
  27. 27.
    K. J. Fehske, W. E. Müller, and U. Wollert, Biochem. Pharmacol.,30, 687–692 (1981).Google Scholar
  28. 28.
    K. J. Fehske, W. E. Müller, and U. Wollert, Molec. Pharmacol.,21, 387–393 (1981).Google Scholar
  29. 29.
    I. Fitos and M. Simonyi, Experientia,39, 591–592 (1983).Google Scholar
  30. 30.
    I. Fitos, M. Simonyi, Z. Tegyey, et al., J. Chromatogr.,259, 494–498 (1983).Google Scholar
  31. 31.
    I. Fitos, Z. Tegyey, M. Simonyi, et al., Biochem. Pharmacol.,35, 263–269 (1986).Google Scholar
  32. 32.
    K. M. Giacomini, W. L. Nelson, R. A. Pershe, et al., J. Pharmacokinet. Biopharm.,14, 335–356 (1986).Google Scholar
  33. 33.
    G. Gratton, E. Decorte, F. Moimas, et al., Farmaco., Ed. Sci.,40, 209–217 (1985).Google Scholar
  34. 34.
    A. S. Gross, B. Heuer, and M. Eichelbaum, Biochem. Pharmacol.,37, 4623–4627 (1988).Google Scholar
  35. 35.
    J. Hermansson, J. Chromatogr.,269, 71–80 (1983).Google Scholar
  36. 36.
    J. Hermansson, ibid.,298, 67–78 (1984).Google Scholar
  37. 37.
    J. Hermansson, ibid.,316, 537–546 (1984).Google Scholar
  38. 38.
    J. Hermansson and M. Eriksson, ibid.,336, 321–328.Google Scholar
  39. 39.
    J. Hermansson, Ibid.,325, 379–384 (1985).Google Scholar
  40. 40.
    J. Hermansson and M. Eriksson, J. Liq. Chromatogr.,9, 621–639 (1986).Google Scholar
  41. 41.
    J. Huang, S. Oie, Res. Commun. Chem. Path. Pharmacol.,41, 227–241 (1983).Google Scholar
  42. 42.
    J. Huang and S. Oie, ibid. pp. 243–253.Google Scholar
  43. 43.
    J. Huang and S. Oie, J. Pharm. Pharmacol.,37, 471–475 (1985).Google Scholar
  44. 44.
    G. P. Jackman, A. J. McLean, G. L. Jennings, et al., Clin. Pharmacol. Ther.,30, 291–296 (1981).Google Scholar
  45. 45.
    S. Kasai, T. Horie, T. Mizuma, and S. Awazu, J. Pharm. Sci.,76, 387–392 (1987).Google Scholar
  46. 46.
    U. Kragh-Hansen, Pharmacol. Rev.,33, 17–53 (1981).Google Scholar
  47. 47.
    J. M. H. Kremer, J. Wilting, and L. H. M. Janssen, ibid.,40, 1–47 (1988).Google Scholar
  48. 48.
    C. Lagercrantz, T. Larsson, and I. Denfors, Comp. Biochem. Physiol.,69C, 375–378 (1981).Google Scholar
  49. 49.
    J. J. Lima, G. L. Jungbluth, T. Devine, and L. W. Robertson, Life Sci.,35, 835–839 (1984).Google Scholar
  50. 50.
    J. J. Lima, H. Boudoulas, and B. J. Shields, Drug Metab. Dispos.,13, 572–577 (1985).Google Scholar
  51. 51.
    J. J. Lima, Life Sci.,41, 2807–2813 (1987).Google Scholar
  52. 52.
    J. J. Lima, Drug Metab. Dispos.,16, 563–567 (1988).Google Scholar
  53. 53.
    T. H. Lin, Y. Sugiyama, Y. Sawada, et al., Biochem. Pharmacol.,37, 2957–2961 (1988).Google Scholar
  54. 54.
    R. H. McMenamy and J. L. Oncley, J. Biol. Chem.,233, 1436–1447 (1975).Google Scholar
  55. 55.
    W. E. Müller and U. Wollert, Molec. Pharmacol.,11, 52–60 (1975).Google Scholar
  56. 56.
    W. E. Müller and U. Wollert, Pharmacology,19, 59–67 (1979).Google Scholar
  57. 57.
    W. E. Müller and A. E. Stillbauer, Naunyn-Schmiedeberg's Arch. Pharmakol.,322, 170–173 (1983).Google Scholar
  58. 58.
    D. Ofori-Adjei, O. Ericsson, B. Lindström, and F. Sjöqvist, Br. J. Clin. Pharmacol.,22, 356–358 (1986).Google Scholar
  59. 59.
    M. Otagiri, Y. Otagiri, and J. H. Perrin, Int. J. Pharm.,2, 283–294 (1979).Google Scholar
  60. 60.
    M. Otagiri, T. Maruyama, T. Imai, et al., J. Pharm. Pharmacol.,39, 416–420 (1987).Google Scholar
  61. 61.
    W. M. Pardridge, R. Sakiyama, and G. Fierer, J. Clin. Invest.,71, 900–908 (1983).Google Scholar
  62. 62.
    T. Peters, Jr., Adv. Protein Chem.,37, 161–245 (1985).Google Scholar
  63. 63.
    G. Powis, Biochem. Pharmacol.,24, 707–712 (1975).Google Scholar
  64. 64.
    S. Rendić, T. Alebić-Kolbah, F. Kajfez, and V. Sunjić, Farmacol. Ed. Sci.,35, 51–59 (1980).Google Scholar
  65. 65.
    S. Rendić, E. Kajfez, G. Gratton, and V. Sunjić, Acta Pharm. Jugsl.,30, 1–7 (1980).Google Scholar
  66. 66.
    M. K. Romach, K. M. Piafsky, J. O. Abel, et al., Clin. Pharmacol. Ther.,29, 211–217 (1981).Google Scholar
  67. 67.
    G. Sager, D. Sandnes, A. Bessesen, and S. Jacobsen, Biochem. Pharmacol.,34, 2812–2815 (1985).Google Scholar
  68. 68.
    D. S. Sampath and P. Balaram, Biochim. Biophys. Acta,882, 183–186 (1986).Google Scholar
  69. 69.
    G. Schill, I. W. Wainer, and S. A. Barkan, J. Liq. Chromatogr.,9, 641–666 (1986).Google Scholar
  70. 70.
    G. Schill, I. W. Wainer, and S. A. Barkan, J. Chromatogr.,365, 73–88 (1986).Google Scholar
  71. 71.
    E. Schillinger, I. Ehrenberg, and K. Lübke, Biochem. Pharmacol.,27, 651–653 (1978).Google Scholar
  72. 72.
    W. Schmidt and E. Jähnchen, Experientia,34, 1323–1324 (1978).Google Scholar
  73. 73.
    A. J. Sedman, D. C. Bloedow, and J. Gal, Res. Commun. Chem. Path. Pharmacol.,38, 165–168 (1982).Google Scholar
  74. 74.
    E. M. Sellers and J. Koch-Weser, Pharmacol. Res. Commun.,7, 331–336 (1975).Google Scholar
  75. 75.
    B. Silber, N. H. G. Holford, and S. Riegelman, J. Pharm. Sci.,71, 699–704 (1982).Google Scholar
  76. 76.
    M. Simonyi, I. Fitos, and Z. Tegyey, J. Chem. Soc. Chem. Commun.,23, 1105–1106 (1980).Google Scholar
  77. 77.
    M. Simonyi, I. Fitos, Z. Tegyey, and L. Ötvös, Biochem. Biophys.-Res. Commun.,97, 1–7 (1980).Google Scholar
  78. 78.
    M. Simonyi and I. Fitos, Biochem. Pharmacol.,32, 1917–1920 (1983).Google Scholar
  79. 79.
    M. Simonyi, I. Fitos, and J. Visy, Trends Pharmacol. Sci.,7, 112–116 (1986).Google Scholar
  80. 80.
    K. Tawara, K. Kawashima, H. Ishikawa, et al., Eur. J. Clin. Pharmacol.,19, 197–203 (1981).Google Scholar
  81. 81.
    B. Testa, Biochem. Pharmacol.,37, 85–92 (1988).Google Scholar
  82. 82.
    S. Togn and W. F. Trager, J. Pharm. Sci.,73, 1671–1673 (1984).Google Scholar
  83. 83.
    S. Urien, E. Albengres, R. Zini, and J. P. Tillement, Biochem. Pharmacol.,31, 3687–3689 (1982).Google Scholar
  84. 84.
    B. Vogelgesang, H. Echizen, E. Schmidt, and M. Eichelbaum, Br. J. Clin. Pharmacol.,18, 733–740 (1984).Google Scholar
  85. 85.
    U. K. Walle, T. Walle, S. A. Bai, and L. S. Olanoff, Clin. Pharmacol. Ther.,34, 718–723 (1983).Google Scholar
  86. 86.
    S. Wanwimolruk, D. J. Birkett, and P. M. Brooks, Molec. Pharmacol.,24, 458–463 (1983).Google Scholar
  87. 87.
    K. J. Whaley, D. S. Sampath, and P. Balaram, Biochem. Biophys. Acta,801, 127–130 (1984).Google Scholar
  88. 88.
    K. Williams and E. Lee, Drugs,30, 333–354 (1985).Google Scholar
  89. 89.
    J. Wilting, W. F. Giesen, L. H. M. van der Janssen, et al., J. Biol. Chem.,255, 3032–3037 (1980).Google Scholar
  90. 90.
    A. Yacobi and G. Levy, J. Pharmacokinet. Biopharm.,5, 123–131 (1977).Google Scholar
  91. 91.
    H. Yamada, T. Ichihashi, K. Hirano, and H. Kinoshita, J. Pharm. Sci.,70, 112–113 (1981).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • A. N. Lutsevich
    • 1
  1. 1.Saratov Medical InstituteUSSR

Personalised recommendations